{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T14:38:10Z","timestamp":1774535890438,"version":"3.50.1"},"reference-count":32,"publisher":"Japanese Society of Internal Medicine","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2169\/internalmedicine.56.8040","type":"journal-article","created":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T22:13:54Z","timestamp":1500070434000},"page":"1825-1829","source":"Crossref","is-referenced-by-count":27,"title":["Gastric Hyperplastic Polyps Associated with Proton Pump Inhibitor Use in a Case without a History of &lt;i&gt;Helicobacter pylori&lt;\/i&gt; Infection"],"prefix":"10.2169","volume":"56","author":[{"given":"Shuichi","family":"Miyamoto","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Hokkaido University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mototsugu","family":"Kato","sequence":"additional","affiliation":[{"name":"National Hospital Organization Hakodate Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kana","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Hokkaido University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Abiko","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Hokkaido University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Momoko","family":"Tsuda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Hokkaido University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Mizushima","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Hokkaido University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Hokkaido University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Ono","sequence":"additional","affiliation":[{"name":"Division of Endoscopy, Hokkaido University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiko","family":"Kudo","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Hokkaido University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Division of Endoscopy, Hokkaido University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanako C.","family":"Hatanaka","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Hokkaido University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izumi","family":"Tsunematsu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Toei Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Hokkaido University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Haastrup PF, Paulsen MS, Christensen RD, Sondergaard J, Hansen JM, Jarbol DE. Medical and non-medical predictors of initiating long-term use of proton pump inhibitors: a nationwide cohort study of first-time users during a 10-year period. Aliment Pharmacol Ther 44: 78-87, 2016."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Boutet R, Wilcock M, MacKenzie I. Survey on repeat prescribing for acid suppression drugs in primary care in Cornwall and the Isles of Scilly. Aliment Pharmacol Ther 13: 813-817, 1999.","DOI":"10.1046\/j.1365-2036.1999.00524.x"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Corley DA, Kubo A, Zhao W, Quesenberry C. Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients. Gastroenterology 139: 93-101, 2010.","DOI":"10.1053\/j.gastro.2010.03.055"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Leonard J, Marshall JK, Moayyedi P. Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol 102: 2047-2056, 2007.","DOI":"10.1111\/j.1572-0241.2007.01275.x"},{"key":"5","unstructured":"5. Hongo M, Fujimoto K; Gastric Polyps Study Group. Incidence and risk factor of fundic gland polyp and hyperplastic polyp in long-term proton pump inhibitor therapy: a prospective study in Japan. J Gastroenterol 45: 618-624, 2010."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kumar KR, Iqbal R, Coss E, Park C, Cryer B, Genta RM. <i>Helicobacter<\/i> gastritis induces changes in the oxyntic mucosa indistinguishable from the effects of proton pump inhibitors. Hum Pathol 44: 2706-2710, 2013.","DOI":"10.1016\/j.humpath.2013.07.015"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Jalving M, Koornstra JJ, Wesseling J, Boezen HM, DE Jong S, Kleibeuker JH. Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy. Aliment Pharmacol Ther 24: 1341-1348, 2006.","DOI":"10.1111\/j.1365-2036.2006.03127.x"},{"key":"8","unstructured":"8. Graham JR. Gastric polyposis: onset during long-term therapy with omeprazole. Med J Aust 157: 287-288, 1992."},{"key":"9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1055\/s-2007-1009061","volume":"26","author":"M Stolte","year":"1994","unstructured":"9. Stolte M, Sticht T, Eidt S, Ebert D, Finkenzeller G. Frequency, location, and age and sex distribution of various types of gastric polyp. Endoscopy 26: 659-665, 1994.","journal-title":"Endoscopy","ISSN":"https:\/\/id.crossref.org\/issn\/0013-726X","issn-type":"print"},{"key":"10","unstructured":"10. Borch K, Skarsgard J, Franzen L, Mardh S, Rehfeld JF. Benign gastric polyps: morphological and functional origin. Dig Dis Sci 48: 1292-1297, 2003."},{"key":"11","unstructured":"11. Elhanafi S, Saadi M, Lou W, et al. Gastric polyps: Association with <i>Helicobacter pylori<\/i> status and the pathology of the surrounding mucosa, a cross sectional study. World J Gastrointest Endosc 7: 995-1002, 2015."},{"key":"12","unstructured":"12. Ji F, Wang ZW, Ning JW, Wang QY, Chen JY, Li YM. Effect of drug treatment on hyperplastic gastric polyps infected with <i>Helicobacter pylori<\/i>: a randomized, controlled trial. World J Gastroenterol 12: 1770-1773, 2006."},{"key":"13","unstructured":"13. Tokunaga K, Tanaka A, Takahashi S. [Gastric hyperplastic polyps and <i>H. pylori<\/i> infection, their relationship and effects of eradication therapy]. Nihon Rinsho 71: 1449-1452, 2013 (in Japanese, Abstract in English)."},{"key":"14","unstructured":"14. Jain R, Chetty R. Gastric hyperplastic polyps: a review. Dig Dis Sci 54: 1839-1846, 2009."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kato M. Endoscopic findings of <i>H. pylori<\/i> infection. In: Helicobacter pylori. Suzuki H, Warren R, Marshall B, Eds. Springer, Japan, 2016: 157-167.","DOI":"10.1007\/978-4-431-55705-0_10"},{"key":"16","unstructured":"16. Parks T, Ragland KL, Steiner MA, Subramony C, Bishop P, Nowicki M. M\u00e9n\u00e9trier mimicker complicating ulcerative colitis: proton-pump inhibitor-induced hyperplastic polyps. J Pediatr 167: 776 e1, 2015."},{"key":"17","unstructured":"17. Alqutub AN, Masoodi I. A case of gastric polyposis in antral area of stomach following prolonged proton-pump therapy. Ger Med Sci 8: Doc 19, 2010."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ito M, Tanaka S, Maeda M, et al. Role of the gastrin-gastrin receptor system in the expansive growth of human gastric neoplasms. Digestion 78: 163-170, 2008.","DOI":"10.1159\/000181146"},{"key":"19","unstructured":"19. Carmack SW, Genta RM, Schuler CM, Saboorian MH. The current spectrum of gastric polyps: a 1-year national study of over 120,000 patients. Am J Gastroenterol 104: 1524-1532, 2009."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ohkusa T, Takashimizu I, Fujiki K, et al. Disappearance of hyperplastic polyps in the stomach after eradication of <i>Helicobacter pylori<\/i>. A randomized, clinical trial. Ann Intern Med 129: 712-715, 1998.","DOI":"10.7326\/0003-4819-129-9-199811010-00006"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Nam SY, Park BJ, Ryu KH, Nam JH. Effect of <i>Helicobacter pylori<\/i> infection and its eradication on the fate of gastric polyps. Eur J Gastroenterol Hepatol 28: 449-454, 2016.","DOI":"10.1097\/MEG.0000000000000553"},{"key":"22","unstructured":"22. Abraham SC, Singh VK, Yardley JH, Wu TT. Hyperplastic polyps of the stomach: associations with histologic patterns of gastritis and gastric atrophy. Am J Surg Pathol 25: 500-507, 2001."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Takamura A, Ito M, Boda T, et al. High expression of gastrin receptor protein in injured mucosa of <i>Helicobacter pylori<\/i>-positive gastritis. Dig Dis Sci 58: 634-640, 2013.","DOI":"10.1007\/s10620-012-2427-6"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Tahara E. Growth factors and oncogenes in human gastrointestinal carcinomas. J Cancer Res Clin Oncol 116: 121-131, 1990.","DOI":"10.1007\/BF01612665"},{"key":"25","unstructured":"25. Waldum HL, Brenna E. [Role of the enterochromaffin-like cells and histamine in the regulation of gastric acid secretion]. Gastroenterol Clin Biol 15: 65C-72C, 1991 (in French)."},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Sekikawa A, Fukui H, Fujii S, et al. REG Ialpha protein may function as a trophic and\/or anti-apoptotic factor in the development of gastric cancer. Gastroenterology 128: 642-653, 2005.","DOI":"10.1053\/j.gastro.2004.12.045"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Steele IA, Dimaline R, Pritchard DM, et al. <i>Helicobacter<\/i> and gastrin stimulate Reg1 expression in gastric epithelial cells through distinct promoter elements. Am J Physiol Gastrointest Liver Physiol 293: G347-G354, 2007.","DOI":"10.1152\/ajpgi.00076.2007"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Bhandari S, Bakke I, Kumar J, et al. Connective tissue growth factor is activated by gastrin and involved in gastrin-induced migration and invasion. Biochem Biophys Res Commun 475: 119-124, 2016.","DOI":"10.1016\/j.bbrc.2016.05.052"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Kazumori H, Ishihara S, Fukuda R, Kinoshita Y. Localization of Reg receptor in rat fundic mucosa. J Lab Clin Med 139: 101-108, 2002.","DOI":"10.1067\/mlc.2002.120796"},{"key":"30","unstructured":"30. Mathieu N. [Risk of long-term treatment with proton pump inhibitors]. Rev Prat 58: 1451-1454, 2008 (in French, Abstract in English)."},{"key":"31","unstructured":"31. Orlowska J, Kupryjanczyk J. Malignant transformation of gastric hyperplastic polyps. Am J Clin Pathol 117: 165-166, 2002."},{"key":"32","unstructured":"32. Ahn JY, Son da H, Choi KD, et al. Neoplasms arising in large gastric hyperplastic polyps: endoscopic and pathologic features. Gastrointest Endosc 80: 1005-1013, 2014."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/14\/56_56.8040\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T08:58:36Z","timestamp":1569833916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/14\/56_56.8040\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":32,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.56.8040","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}